Soluble mediators of immunity: interleukins

  • F. S. Di Giovine
  • J. A. Symons
  • J. Manson
  • G. W. Duff

Abstract

Interleukins were denned originally as inducible peptide cytokines that mediated interactions between leukocytes1. This definition was soon revised when it became clear that interleukin-1 (IL-1), in particular, was active on many non-leukocytic cell types and was not made exclusively by leukocytes2.

Keywords

Mast Cell Soluble Mediator Lymphokine Activate Killer Cell Haemopoietic Cell Cell Stimulatory Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aarden, L.A., Brunner, T.K., Cerottini, J.C. et al. (1979). Revised nomenclature for antigen-non-specific T cell proliferation and helper factors (letter). J. Immunol., 123, 2928–9Google Scholar
  2. 2.
    Oppenheim, J.J. and Gery, I. (1982). Interleukin 1 is more than an interleukin. Immunol. Today., 3, 113–19Google Scholar
  3. 3.
    Pettipher, E.R., Higgs, G.A. and Henderson, B. (1986). Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA, 83, 8749–53PubMedGoogle Scholar
  4. 4.
    Gery, I., Gershon, R.K. and Waksman, B.H. (1972). Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J. Exp. Med., 136, 128–42PubMedGoogle Scholar
  5. 5.
    Durum, S.K., Schmidt, J.A. and Oppenheim, J.J. (1985). Interleukin 1: an immunological perspective. In Paul, W.E., Fathman, C.G. and Metzger, H. (eds.) Annual Review of Immunology, pp. 263–87. (California: Annual Reviews Inc)Google Scholar
  6. 6.
    Dinarello, C.A. (1986). Interleukin-1: Amino acid sequences, multiple biological activities and comparison with tumour necrosis factor (cachectin). In Cruse, J.M., Lewis, R.E. and Jackson, M. (eds.) The Year in Immunology. Vol. 2, pp. 68–89. (Basel: Karger)Google Scholar
  7. 7.
    Dinarello, C.A., Cannon, J.G., Mier, J.W., Bernheim, H.A., LoPreste, G., Lynn, D.L., Love, R.N., Webb, A.C., Auron, P.E., Reuben, R.C, Rich, A., Wolff, S.M. and Putney, S.D. (1986). Multiple biological activities of human recombinant interleukin 1. J. Clin. Invest., 77, 1734–9PubMedGoogle Scholar
  8. 8.
    Furutani, Y., Notake, M., Yamayoshi, M., Yamagishi, J., Nomura, H., Ohue, M., Fukui, T., Yamada, M. and Nakamura, S. (1985). Cloning and characterizaton of the cDNAs for human and rabbit interleukin-1 precursor. Nucl. Acids Res., 13, 5869–82PubMedGoogle Scholar
  9. 9.
    Lomedico, P., Gubler, U., Hellman, C.P., Dukovitch, M., Giri, J.G., Pan, Y.E., Collier, K., Semionow, R., Chua, A.O. and Mizel, S.B. (1984). Cloning and expression of murine interleukin 1 cDNA in Escherichia coli. Nature, 312, 458–62PubMedGoogle Scholar
  10. 10.
    Rosenwasser, L.J., Webb, A.C., Clark, B.D., Ihrie, S., Dinarello, C.A., Gehrk, L., Wolff, S.M., Rich, A. and Auron, P.E. (1986). Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells. Proc. Natl. Acad. Sci. USA, 83, 5243–46PubMedGoogle Scholar
  11. 11.
    Furutani, Y., Notake, M., Fukui, T., Ohue, M., Nomura, H., Yamada, M. and Nakamura, S. (1986). Complete nucleotide sequence of the gene for human interleukin-1α. Nucl. Acids Res., 14, 3167–79PubMedGoogle Scholar
  12. 12.
    Clark, B.D., Collins, K.L., Gandy, M.S., Webb, A.C. and Auron, P.E. (1986). Genomic sequence for human pro-interleukin-lβ — possible evolution from a reverse transcribed pro-interleukin-1α gene. Nucl. Acids Res., 14, 7897–914PubMedGoogle Scholar
  13. 13.
    Telford, J.L., Macchia, G., Massone, A., Carina, V., Palla, E. and Melli, E. (1986). The murine interleukin-103B2 gene: structure and evolution. Nucl. Acids. Res., 14, 9955–63PubMedGoogle Scholar
  14. 14.
    Bensi, G., Raugei, G., Palla, E., Carinci, V., Buonamassa, D. and Melli, M. (1987). Human interleukin-iβ gene. Gene52, 95–101PubMedGoogle Scholar
  15. 15.
    Perlmutter, D.H., Goldberger, G., Dinarello, C.A., Mizel, S.B. and Colton, H.R. (1986). Regulation of class III major histocompatibility complex gene products by interleukin 1. Science, 232, 850–2PubMedGoogle Scholar
  16. 16.
    Krane, S.M. (1987). Modulation of matrix synthesis and degradation in joint inflammation. Presented at the Strangeways Research Laboratory 75th Anniversary Symposium, April 6–8, CambridgeGoogle Scholar
  17. 17.
    Warner, S.J., Auger, K.R. and Libby, P. (1987). Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med., 165, 1316–31PubMedGoogle Scholar
  18. 18.
    Bevilacquea, M.P., Pober, J.S., Majeau, G.R., Contran, R.S. and Gimbrone, M.A. (1984). Interleukin 1 (ILl) induced biosynthesis and cell surface expression of procoagulation activity in human vascular endothelial cells. J. Exp. Med., 160, 618–23Google Scholar
  19. 19.
    Lowenthal, J.W., Cerottini, J.C. and MacDonald, H.R. (1986). Interleukin 1 dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J. Immunol., 137, 1226–31PubMedGoogle Scholar
  20. 20.
    Di Giovine, F., Malawista, S.E., Nuki, G. and Duff, G.W. (1987). Interleukin 1 (IL-1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL-1. J. Immunol., 138, 3213–8PubMedGoogle Scholar
  21. 21.
    March, C.J., Mosley, B., Larsen, A., Cerretti, D.P., Braedt, G., Price, V., Gillis, S., Henney, C, Krortheim, S.R., Grabstein, K., Conlon, P.J., Hopp, T.P. and Cosman, D. (1985). Cloning, sequence and expression of two distinct human interleukin 1 complementary DNAs. Nature, 315, 641–7PubMedGoogle Scholar
  22. 22.
    Dinarello, C.A., Cannon J.G., Wolff, S.M., Bernheim, H.A., Beutler, B., Cerami, A., Figari, I.S., Palladino, M.A. and O’Connor, J.V. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med., 163, 1433–50PubMedGoogle Scholar
  23. 23.
    Gery, I., Davies, P., Derr, J., Kreh, N. and Barranger, J.A. (1981). Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. I. Effects of various agents. Cell Immunol., 64, 293–303PubMedGoogle Scholar
  24. 24.
    Dower, S.K., Kronheim, S.R., March, C.J., Conlon, P.J., Hopp, T.D., Gillis, S. and Vral, D. (1985). Detection and characterisation of high affinity plasma membrane receptors for human interleukin 1. J. Exp. Med., 162, 501–15PubMedGoogle Scholar
  25. 25.
    Bird, T.A. and Saklatvala, J. (1986). Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature, 324, 263–6PubMedGoogle Scholar
  26. 26.
    Mosley, B., Urdal, D.L., Prickett, K.S., Larsen, A., Cosman, D., Conlon, P.J., Gillis, S. and Dower, S.K. (1987). The interleukin 1 receptor binds the human interleukin-1α precursor but not the interleukin-iβ precursor. J. Biol Chem., 262, 2941–4PubMedGoogle Scholar
  27. 27.
    Lowenthal, J.W. and MacDonald, H.R. (1986). Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J. Exp. Med., 164, 1060–74PubMedGoogle Scholar
  28. 28.
    Gillis, S., Ferm, M.M., Ou, W. and Smith, K.A. (1978). T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol., 120, 2027–32PubMedGoogle Scholar
  29. 29.
    Pfizenmaier, K., Scheurich, P., Daukener, W., Kronke, M., Rollinghoff, M. and Wagner, H. (1984). Quantitative representation of all T cells committed to develop into cytotoxic effector cells and/or interleukin 2 activity-producing helper cells within murine T lymphocyte subsets. Eur. J. Immunol., 14, 33–9PubMedGoogle Scholar
  30. 30.
    Robb, R.J. and Smith, K.A. (1981). Heterogeneity of human T-cell growth factor(s) due to variable glycosilation. Mol. Immunol., 18, 1087–94PubMedGoogle Scholar
  31. 31.
    Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R. and Hamuro, J. (1983). Structure and expression of a cloned cDNA for human interleukin-2. Nature, 302, 305–10PubMedGoogle Scholar
  32. 32.
    Mita, S., Maeda, S. and Shimada, K. (1986). Characterization of human genomic DNA sequences homologous to the interleukin 2 cDNA. Biochem. Biophys. Res. Commun., 138, 966–73PubMedGoogle Scholar
  33. 33.
    Uchiyama, T., Broder, S. and Waldmann, T.A. (1981). A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. 1. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol., 126, 1393–7PubMedGoogle Scholar
  34. 34.
    Robb, R.J., Greene W.C. and Rusk, C.M. (1984). Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J. Exp. Med., 160, 1126–46PubMedGoogle Scholar
  35. 35.
    Smith, K.A. and Cantrell, D.A. (1985). Interleukin 2 regulates its own receptors. Proc. Natl. Acad. Sci. USA, 82, 864–8PubMedGoogle Scholar
  36. 36.
    Smith, K.A. (1987). The two-chain structure of high-affinity IL-2 receptors. Immunol. Today, 8, 11–13Google Scholar
  37. 37.
    Benveniste, E.N. and Merrill, J.E, (1986). Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature, 321, 610–13PubMedGoogle Scholar
  38. 38.
    Farrar, W.L. and Taguchi, M. (1985). Stimulation of protein kinase C membrane association: evidence for IL-2 receptor phosphorylation. Lymphokine Res., 4, 87–93PubMedGoogle Scholar
  39. 39.
    Farrar, W.L., Johnson, M.M. and Farrar, J.J. (1981). Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin-2. J. Immunol., 126, 1120–5PubMedGoogle Scholar
  40. 40.
    Vilcek, J., Henriksen-DeStefano, D., Siegel, D., Klion, A., Robb, R.J. and Le, J. (1985). Regulation of IFN-γ induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J. Immunol., 135, 1851–6PubMedGoogle Scholar
  41. 41.
    Henney, C.S., Kuribayashi, K., Kern, D.E. and Gillis, S. (1981). Interleukin 2 augments natural killer cell activity. Nature, 291, 335–7PubMedGoogle Scholar
  42. 42.
    Mingari, M.C., Gerosa, F., Carra, G., Accolla, R.S., Moretta, A., Zubler, R.H., Waldmann, T.A. and Moretta, L. (1984). Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature, 312, 641–3PubMedGoogle Scholar
  43. 43.
    Malkovsky, M., Loveland, B., North, M., Asherson, G.L., Garo, L., Ward, P. and Fiers, W. (1987). Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature, 325, 262–5PubMedGoogle Scholar
  44. 44.
    Herrmann, F., Cannistra, S.A., Levine, H. and Griffin, J.D. (1985). Expression of interleukin 2 receptors and binding of interleukin 2 by y-interferon-induced human leukemic and normal monocytic cells. J. Exp. Med., 162, 1111–16PubMedGoogle Scholar
  45. 45.
    Nakayama, E., Asano, S., Takuwa, N., Yokota, J. and Miwa, S. (1983). Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. Clin. Exp. Immunol., 51, 511–16PubMedGoogle Scholar
  46. 46.
    Zamkofï, K.W., Reeves, W.G., Paolozzi, F.P., Poiesz, B.J., Comis, R.L. and Tomar, R.H. (1985). Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin’s disease. Clin. Immunol. Immunopathol., 35, 111–24Google Scholar
  47. 47.
    Yoshioka, K., Kakumu, S., Murakami, H. and Fukui, K. (1984). Interleukin 2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction. Clin. Exp. Immunol., 54, 668–76Google Scholar
  48. 48.
    Miyasaka, N., Nakamura, T., Russell, I.J. and Talal, N. (1984). Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin. Immunol. Immunopathol., 31, 109–17PubMedGoogle Scholar
  49. 49.
    Merrill, J.E., Mohlstrom, C., Uittenbogaart, C., Kermani-Arab, V., Ellison, G.W. and Myers, L.W. (1984). Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J. Immunol., 133, 1931–7PubMedGoogle Scholar
  50. 50.
    Linker-Israeli, M., Bakke, A.C., Quismorio, F.P. and Horwitz, D.A. (1985). Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J. Clin. Invest., 75, 762–8PubMedGoogle Scholar
  51. 51.
    Rosenberg, S.A. and Lotze, M.T. (1986). Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. In Paul, W.E., Fathman, C.G. and Metzger, H. (eds.) Annual Review of Immunology, pp. 681–709. (California: Annual Reviews Inc.)Google Scholar
  52. 52.
    Metealf, D. (1985). The granulocyte—macrophage colony-stimulating factors. Science, 229, 16–22Google Scholar
  53. 53.
    Schrader, J.W. (1986). The panspecific hemopoietin of activated T lymphocytes (interleukin 3). In Paul, W.E., Fathman, GG. and Metzger, H. (eds.) Annual Review of Immunology. pp. 205–230. (California: Annual Reviews Inc.)Google Scholar
  54. 54.
    Yang, Y.G, Ciarletta, A.B., Temple, P.A., Chung, M.P., Kovacic, S., Witek-Giannotti, J.S., Leary, A.C., Kriz, R., Donahue, R.E., Wong, G.G. and Clark, S.C. (1986). Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell, 47, 3–10PubMedGoogle Scholar
  55. 55.
    Barlow, D.P., Bucan, M., Lehrach, H., Hogan, B.L.M. and Gough, N.M. (1987). Close genetic and physical linkage between murine haemopoietic growth factor genes GM-CSF and multi-CSF (IL-3). EMBO J., 6, 617–23PubMedGoogle Scholar
  56. 56.
    Ihle, J.N., Lee, J.G. and Rebar, L. (1981). T cell recognition of Moloney leukemia virus proteins. III T cell proliferative responses against gp 70 are associated with the production of a lymphokine inducing 20 alpha hydroxysteroid dehydrogenase in splenic lymphocytes. J. Immunol., 127, 2565–70PubMedGoogle Scholar
  57. 57.
    Glasebrook, A.L. and Fitch, F.W. (1980). Alloreactive T cell lines. I. Interactions between cloned amplifier and cytotoxic T cell lines. J. Exp. Med., 151, 876–95PubMedGoogle Scholar
  58. 58.
    Frei, K., Bodmer, S., Schwerdel, C. and Fontana, A. (1985). Astrocytes of the brain synthesize interleukin-3-like factors. J. Immunol., 135, 4044–7PubMedGoogle Scholar
  59. 59.
    Clark-Lewis, I., Kent, S.B.H. and Schrader, J.W. (1984). Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of haemopoietic cells. J. Biol Chem., 259, 7488–94PubMedGoogle Scholar
  60. 60.
    Wong, G.H.W., Clark-Lewis, I., Hamilton, J.A. and Schrader, J.W. (1984). P-cell stimulating factor and glucocorticoids oppose the action of interferon-γ in inducing Ia antigens on T-dependent mast cells (P cells). J. Immunol., 133, 2043–50PubMedGoogle Scholar
  61. 61.
    Hapel, A.J., Lee, J.C., Farrar, W.L. and Ihle, J.N. (1981). Establishment of continuous cultures of Thy-1.2+ Lyt-l+,2 T cells with purified interleukin-3. Cell, 25, 179–86PubMedGoogle Scholar
  62. 62.
    Nicola, N.A. (1987). Why do haemopoietic growth factor receptors interact with each other? Immunol. Today, 8, 134–40Google Scholar
  63. 63.
    Palacios, R., Henson, G., Steinmetz, M. and McKearn, J.P. (1984). Interleukin-3 supports growth of mouse pre-B-cell clones in vitro. Nature, 309, 126–31PubMedGoogle Scholar
  64. 64.
    Pike, B.L. and Nossal, G.J.V. (1985). A high efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors. Proc. Natl. Acad. Sci. USA, 82, 3395–9PubMedGoogle Scholar
  65. 65.
    Crapper, R.M., Clark-Lewis, I. and Schrader, J.W. (1984). The in vivo functions and properties of persisting cell stimulating factor. Immunology, 53, 33–42PubMedGoogle Scholar
  66. 66.
    Crapper, R.M. and Schrader, J.W. (1986). Evidence for the in vivo production and release into the serum of a T cell lymphokine, persisting-cell stimulating factor (PSF) during graft-vs-host reactions. Immunology, 57, 553–8PubMedGoogle Scholar
  67. 67.
    Gordon, M.Y., Riley, G.P., Watt, S.M. and Greaves, M.F. (1987). Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature, 326, 403–5PubMedGoogle Scholar
  68. 68.
    Schrader, J.W and Crapper, R.M. (1983). Autogenous production of a hemopoietic growth factor ‘P cell stimulating factor’ as a mechanism for transformation of bone-marrow derived cells. Proc. Natl. Acad. Sci. USA, 80, 6892–6PubMedGoogle Scholar
  69. 69.
    Henney, C. (1986). Therapeutic potential for colony stimulating factors. Presented at the conference on Cytokines and Other Mediators in Inflammatory Diseases, December 1–2, LondonGoogle Scholar
  70. 70.
    Kishimoto, T. (1985). Factors affecting B-cell growth and differentiation. In Paul, W.E., Fathman, C.G. and Metzger, H. (eds.), Annual Review of Immunology, pp. 133–57. (California: Annual Reviews Inc.)Google Scholar
  71. 71.
    Melchers, F. and Andersson, J. (1986). Factors controlling the B-cell cycle. In Paul, W.E., Fathman, C.G. and Metzger, H. (eds.), Annual Review of Immunology, pp. 13–36. (California: Annual Reviews Inc.)Google Scholar
  72. 72.
    Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T. and Paul, W.E. (1982). Identification of a T-cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med., 155, 914–23PubMedGoogle Scholar
  73. 73.
    Ohara, J., Lahet, S., Inman, J. and Paul, W.E. (1985). Partial purification of murine B cell stimulatory factor (BSF)-l. J. Immunol., 135, 2518–23PubMedGoogle Scholar
  74. 74.
    Muraguchi, A., Kasahara, T., Oppenheim, J.J. and Fauci, A.S. (1982). B cell growth factor and T cell growth factor produced by mitogen stimulated normal human peripheral blood T lymphocytes are distinct molecules. J. Immunol., 129, 2486–9PubMedGoogle Scholar
  75. 75.
    Rabin, E.M., Ohara, J. and Paul, W.E. (1985). B cell stimulatory factor 1 activates resting B cells. Proc. Natl. Acad. Sci. USA, 82, 2935–9PubMedGoogle Scholar
  76. 76.
    Oliver, K., Noelle, R.J., Uhr, J.W., Krammer, P.H. and Vitetta, E.S. (1985). B cell growth factor (B cell growth factor 1 or B cell-stimulating factor provisional 1) is a differentiating factor for resting B cells and may not induce cell growth. Proc. Natl. Acad. Sci. USA, 80, 2465–7Google Scholar
  77. 77.
    Noma, Y., Sideras, P., Naito, T., Bergstedt-Lindqvist, S., Azuma, C., Severinson, E., Tanabe, T., Kinashi, T., Matsuda, F., Yaoita, Y. and Honjo, T. (1986). Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature, 319, 640–6PubMedGoogle Scholar
  78. 78.
    Lee, F., Yokota, T., Otsuka, T., Meyerson, P., Villaret, D., Coltman, R., Mosmann, T., Rennick, D., Roehm, N. and Smith, C. (1986). Isolation and characterization of a mouse interleukin cDNA clone that expresses B cell stimulatory factor 1 activities and T cell and mast cell stimulating activities. Proc. Natl. Acad. Sci. USA, 83, 2061–5PubMedGoogle Scholar
  79. 79.
    Yokota, T., Otsuka, T., Mosmann, T., Banchereau, J., DeFrance, T., Blanchard, D., Vries, J.E., Lee, F. and Arai, K.I. (1986). Isolation and characterization of human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that express B cell and T cell stimulating activities. Proc. Natl Acad. Sci. USA, 83, 5894–8PubMedGoogle Scholar
  80. 80.
    Farrar, J.J., Howard, M., Fuller-Farrar, J. and Paul, W.E. (1983). Biochemical and physicochemical characterisation of mouse B cell growth factor: a lymphokine distinct from interleukin 2. J. Immunol., 131, 1838–42PubMedGoogle Scholar
  81. 81.
    Ohara, J. and Paul, W.E. (1987). Receptors for B-cell stimulating factor-1 expressed on cells of haematopoietic lineage. Nature, 325, 537–40PubMedGoogle Scholar
  82. 82.
    Mosmann, T.R., Yokota, T., Kastelein, R., Zurawski, S.M., Arai, N. and Takebe, Y. (1987). Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL-4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL-4). J. Immunol., 138, 1813–16PubMedGoogle Scholar
  83. 83.
    Vitetta, E.S., Brooks, K., Chen, Y.W., Isakson, P., Jones, S., Layton, J., Mishra, G.C., Pure, E., Weiss, E., Word, C., Yuan, D., Tucker, P., Uhr, J.W. and Krammer, P.H. (1984). T cell derived lymphokines that induce IgM and IgG secretion in activated murine B cells. Immunol. Rev., 78, 137–57PubMedGoogle Scholar
  84. 84.
    Rabin, E.M., Mond, J.J., Ohara, J. and Paul, W.E. (1986). Interferon gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells. J. Immunol., 137, 1573–6PubMedGoogle Scholar
  85. 85.
    Noelle, R., Krammer, P.H., Ohara, J., Uhr, J.W. and Vitetta, E.S. (1984). Increased expression of 1a antigens on resting B cells: an additional role for B cell growth factor. Proc. Natl. Acad. Sci. USA, 81, 6149–53PubMedGoogle Scholar
  86. 86.
    Roehm, N.W., Leibson, H.J., Zlotnik, A., Kappler, J., Marrack, P. and Cambier, J.C. (1984). Interleukin induced increase in 1a expression by normal mouse B cells. J. Exp. Med., 160, 679–94PubMedGoogle Scholar
  87. 87.
    Yokota, T., Otsuka, T., Takebe, Y., Mosmann, T., Banchereau, J., DeVries, J., Arai, N., Miyaijima, A., Lee, F. and Arai, K. (1987). Isolation and characterisation of mouse and human IL-4 genes that express B cell T cell and mast cell stimulating activities. Lymphokine Res., 6, 1817AGoogle Scholar
  88. 88.
    Alderson, M.R., Pike, B.L. and Nossal, G.J.V. (1987). Effects of antigens and lymphokines on early activation of single hapten-specific B lymphocytes. J. Immunol., 138, 1056–63PubMedGoogle Scholar
  89. 89.
    Vitetta, E.S., Ohara, J., Myers, C.D., Layton, J.E., Krammer, P.H. and Paul, W.E. (1985). Serological, biochemical and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med., 162, 1726–31PubMedGoogle Scholar
  90. 90.
    Coffman, R.L. and Carty, J. (1986). A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol., 136, 949–54PubMedGoogle Scholar
  91. 91.
    Banchereau, J., DeFrance, T., Rousset, F., Aubry, J.P., Vaubervliet, B., Bonnefoy, J.Y., Arai, N., Takebe, Y., Yokota, T., Lee, F., Arai, K. and de Vries, J.E. (1987). The pleiotropic effects of recombinant human IL-4 on B lymphocytes. Lymphokine Res., 6, 1816AGoogle Scholar
  92. 92.
    Mosmann, T.R., Bond, M.W., Coffman, R.H., Ohara, J. and Paul, W.E. (1986). T cell and mast cell lines respond to B cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA, 83, 5654–8PubMedGoogle Scholar
  93. 93.
    Hu-Li, J., Shevach, E.M., Mizuguchi, J., Ohara, J., Mosmann, T. and Paul, W.E. (1987). B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J. Exp. Med., 165, 157–72PubMedGoogle Scholar
  94. 94.
    Spits, H., Yssel, H., Aray, K., Takebe, Y., Yokota, T., Lee, F., Arai, N., Banchereau, J. and de Vries, J.E. (1987). The effects of recombinant human IL-4 on T cells. Lymphokine Res., 6, 1815AGoogle Scholar
  95. 95.
    Lichtman, A.H., Kurt-Jones, E.A. and Abbas, A.K. (1987). B cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc. Natl. Acad. Sci. USA, 84, 824–7PubMedGoogle Scholar
  96. 96.
    Palacios, R., Sideras, P. and von Boehmer, H. (1987). Recombinant interleukin 4/BSF-l promotes growth and differentiation of intrathymic T cell precursors from fetal mice in vitro. EMBO J, 6, 91–5PubMedGoogle Scholar
  97. 97.
    Finkelman, F.D., Ohara, J., Goroff, D.K., Smith, J., Villacreses, N., Mond, J.J. and Paul, W.E. (1986). Production of BSF-1 during all in vivo T-dependent immune response. J. Immunol., 137, 2878–85PubMedGoogle Scholar
  98. 98.
    Schimpl, A. and Wecker, E. (1972). Replacement of T cell function by a T cell product. Nature, 237, 15–17Google Scholar
  99. 99.
    Takatsu, K., Tominaga, A. and Hamaoka, T. (1980). Antigen-induced T cell-replacing factor (TRF). I. Functional characterization. J. Immunol., 124, 2414–22PubMedGoogle Scholar
  100. 100.
    Azuma, C., Tanabe, T., Konishi, M., Kinash, T., Noma, T., Matsuda, F., Yaoita, Y., Takatsu, K., Hammarstrom, L., Smith, C.I., Severinson, E. and Honjo, T. (1986). Cloning of cDNA for human T cell-replacing factor (interleukin 5) and comparison with the murine homologue. Nucl. Acids Res., 14, 9149–58PubMedGoogle Scholar
  101. 101.
    Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt-Lindqvist, S., Takahashi, M., Matsuda, F., Yaoita, Y., Takatsu, K. and Honjo, T. (1986). Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature, 324, 70–3PubMedGoogle Scholar
  102. 102.
    Harada, N., Kikuchi, Y., Tominaga, A., Takaki, S. and Takatsu, K. (1985). BCGF II activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J. Immunol., 134, 3944–51PubMedGoogle Scholar
  103. 103.
    Takatsu, K., Harada, N., Hara, Y., Takahama, Y., Yamada, G., Dobashi, K. and Hamaoka, T. (1985). Purification and physiochemical characterisation of murine T cell replacing factor (TRF). J. Immunol., 134, 382–9PubMedGoogle Scholar
  104. 104.
    Sanderson, C.J., Warren, D.J. and Strath, M. (1985). Identification of a lymphokine that stimulates eosinophil differentiation in vitro. J. Exp. Med., 162, 60–79PubMedGoogle Scholar
  105. 105.
    Sanderson, C.J., O’Garra, A., Warren, D.J. and Klaus, G.G. (1986). Eosinophil differentiation factor also has B cell growth factor activity-proposed name interleukin 4. Proc. Natl. Acad. Sci. USA, 83, 437–40PubMedGoogle Scholar
  106. 106.
    Swain, S.L., Kubota, E., Heistrom, H. and Dutton, R.W. (1987). Roles of antigen, direct T-B interaction and BCGF II in proliferation and differentiation of B cells. Lymphokine Res., 6, 1803AGoogle Scholar
  107. 107.
    Takacs, L., Berzofsky, J.A., York-Jolley, J., Akahoshi, T., Blasi, E. and Durum, S.K. (1987). IL-1 induction by murine T cell clones: detection of an IL-1 inducing lymphokine. J. Immunol., 138, 2124–31PubMedGoogle Scholar
  108. 108.
    Del Guercio, P., Zanetti, M., Del Guercio, M.F. and Katz, D.H. (1985). B lymphocyte regulation of the immune system. II Inhibition of Fc receptor expression of lymphocytes by BEF, a lymphokine of B cell origin. J. Immunol., 134, 3926–33PubMedGoogle Scholar
  109. 109.
    Billiau, A. (1987). Interferon β2 as a promoter of growth and differentiation of B cells. Immunol. Today, 8, 84–7Google Scholar
  110. 110.
    Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T. and Kishimoto, T. (1986). Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 324, 73–6PubMedGoogle Scholar
  111. 111.
    Zilberstein, A., Ruggieri, R., Korn, J.H. and Revel, M. (1986). Structure and expression of cDNA and genes for human interferon beta 2, a distinct species inducible by growth stimulatory cytokines. EMBO J., 5, 2529–37PubMedGoogle Scholar

Copyright information

© MTP Press Limited 1988

Authors and Affiliations

  • F. S. Di Giovine
  • J. A. Symons
  • J. Manson
  • G. W. Duff

There are no affiliations available

Personalised recommendations